Emergency Contraceptive Pills Market
完整報告名稱與涵蓋範圍
Emergency Contraceptive Pills Market Size, Share & Trends Analysis Report By Type (Combination Pills, Progesterone Pills, Others), By Distribution Channel (Retail Stores, Online Stores, Others), By Region, And By Segment Forecasts, 2025-2034
報告摘要
The worldwide Emergency Contraceptive Pills Market stood at USD 602.3 Million in 2024, and is anticipated to reach USD 1,015.3 Million by 2034, recording a CAGR of 6.3% from 2025 through 2034.
At its core, Emergency Contraceptive Pills pertains to a method of hormonal control that is used to avoid conception following illicit sexual activity or failure of contraceptives. Stakeholders across the healthcare landscape are expandingly turning to these solutions to meet contemporary demands.
Market momentum is underpinned by expanding interest in advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region anticipated to deliver the strongest growth trajectory through the forecast period, underpinned by demographic shifts and policy support.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Emergency Contraceptive Pills Market Snapshot
Chapter 4. Global Emergency Contraceptive Pills Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Emergency Contraceptive Pills Market Industry Trends
4.10. Global Emergency Contraceptive Pills Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Emergency Contraceptive Pills Market Segmentation 1: By Type, Estimates & Trend Analysis
5.1. Market Share by Type, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type:
5.2.1. Combination Pills
5.2.2. Progesterone Pills
5.2.3. Others
Chapter 6. Emergency Contraceptive Pills Market Segmentation 2: By Distribution Channel, Estimates & Trend Analysis
6.1. Market Share by Distribution Channel, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Distribution Channel:
6.2.1. Retail Stores
6.2.2. Online Stores
6.2.3. Others
Chapter 7. Emergency Contraceptive Pills Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. Global Emergency Contraceptive Pills Market, Regional Snapshot 2024 & 2034
7.2. North America
7.2.1. North America Emergency Contraceptive Pills Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
7.2.1.1. US
7.2.1.2. Canada
7.2.2. North America Emergency Contraceptive Pills Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
7.2.3. North America Emergency Contraceptive Pills Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
7.3. Europe
7.3.1. Europe Emergency Contraceptive Pills Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
7.3.1.1. Germany
7.3.1.2. U.K.
7.3.1.3. France
7.3.1.4. Italy
7.3.1.5. Spain
7.3.1.6. Rest of Europe
7.3.2. Europe Emergency Contraceptive Pills Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
7.3.3. Europe Emergency Contraceptive Pills Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
7.4. Asia Pacific
7.4.1. Asia Pacific Emergency Contraceptive Pills Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
7.4.1.1. India
7.4.1.2. China
7.4.1.3. Japan
7.4.1.4. Australia
7.4.1.5. South Korea
7.4.1.6. Southeast Asia
7.4.1.7. Rest of Asia Pacific
7.4.2. Asia Pacific Emergency Contraceptive Pills Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
7.4.3. Asia Pacific Emergency Contraceptive Pills Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
7.5. Latin America
7.5.1. Latin America Emergency Contraceptive Pills Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
7.5.1.1. Brazil
7.5.1.2. Mexico
7.5.1.3. Rest of Latin America
7.5.2. Latin America Emergency Contraceptive Pills Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
7.5.3. Latin America Emergency Contraceptive Pills Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
7.6. Middle East & Africa
7.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.6.1.1. GCC Countries
7.6.1.2. South Africa
7.6.1.3. Rest of Middle East and Africa
7.6.2. Middle East & Africa Emergency Contraceptive Pills Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
7.6.3. Middle East & Africa Emergency Contraceptive Pills Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Afaxys Pharma LLC
8.2.1.1. Business Overview
8.2.1.2. Key Service/Service Overview
8.2.1.3. Financial Performance
8.2.1.4. Geographical Presence
8.2.1.5. Recent Developments with Business Strategy
8.2.2. Bayer AG
8.2.3. Combe Inc.
8.2.4. Foundation Consumer Healthcare LLC
8.2.5. Gedeon Richter Plc
8.2.6. HLL Lifecare Ltd.
8.2.7. Knoll Healthcare Pvt. Ltd.
8.2.8. Laboratoire HRA Pharma SAS
8.2.9. Lupin Ltd.
8.2.10. Mankind Pharma Ltd.
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們